To evaluate the efficacy and the safety profile of Rhubarb and alpha-Keto amino acid supplementation on patients of Chronic kidney disease.

Phase 4

Completed

• Conditions: Health Condition 1: null- Chronic kidney disease

• Registration Number: CTRI/2012/09/002947
• Lead Sponsor: Department Of Pharmacology And Department Of Medicine

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 24 November 2021

Recruitment & Eligibility

• Status: Completed
• Sex: Not specified
• Target Recruitment: 100

Inclusion Criteria

•Chronic kidney disease of different etiology, before ESRD.

•Patient not on dialysis.

Exclusion Criteria

•Pregnancy

•Acute infection

•Psychotic patient

•Critically ill patient

•HIV/HBsAg/Anti-HCV and immunocompromised patient.

•Severe Renal pathology such as malignancy

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
1.Haemogram <br/ ><br>2.Urine- Routine & Microscopic <br/ ><br>3.Blood Glucose <br/ ><br>4.Total Urine Protein(TUP) <br/ ><br>5.Blood Urea <br/ ><br>6.Serum Creatinine <br/ ><br>7.Urine Creatinine <br/ ><br>Timepoint: Pre-dose and after 1st 2nd 3rd month after starting dosing

Secondary Outcome Measures

Name	Time	Method
1.USG-Both kidneys <br/ ><br>2.Chest X-ray( PA VIEW) <br/ ><br>Timepoint: Pre-dose and after 3 month post-dose.